Boston Partners
NEUE

Boston Partners’s NeueHealth NEUE Stock Holding History

Boston Partners’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,117
Closed -$3.11M – 744
2022
Q1 		$3.11M Sell
20,117
-23,523
-54% -$5.22M ﹤0.01% 426
2021
Q4 		$11.9M Buy
+43,640
New +$20.1M 0.01% 350

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Boston Partners's NEUE Position: Q2 2022 in Review

Boston Partners sold out of NeueHealth (NEUE) in Q2 2022, closing a stake of 20,117 shares — an estimated $3.11M sold.

Boston Partners first reported a position in NEUE in Q4 2021 and held it in 2 quarters. The position peaked at $11.9M in Q4 2021. 128 funds tracked by Wall St. Rank hold NEUE as of Q2 2022.

  • Boston Partners reported no remaining NeueHealth position as of Q2 2022 after selling out during the quarter.
  • Boston Partners sold 20,117 NeueHealth shares in Q2 2022, an estimated $3.11M.
  • Boston Partners first reported a position in NeueHealth in Q4 2021 and held it in 2 quarters.
  • Boston Partners's NeueHealth position peaked at $11.9M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held NeueHealth as of Q2 2022.

Based on Boston Partners's 13F filing for Q2 2022, filed 10 Aug 2022.